Effectiveness of ezetimibe in clinical practice

American Journal of Cardiology

Volumn 93, Issue 5, 2004, Pages 641-643

  Jurado, Javier ^b   Seip, Richard ^b   Thompson, Paul D ^a  

^a HARTFORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; EDEMA; EYELID EDEMA; HUMAN; HYPERCHOLESTEROLEMIA; LIP DISEASE; LIP EDEMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 1442299757     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.11.040     Document Type: Article

References (5)

1. Catapano A.L. Ezetimibe a selective inhibitor of cholesterol absorption. Eur Heart J. 3:2001;E6-E10.
2. Sudhop T., Lutjohann D., Kodal A., Igel M., Tribble D.L., Shah S., Perevozskaya I., von Bergmann K. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation. 106:2002;1943-1948.
3. Miettinen T.A. Cholesterol absorption inhibition a strategy for cholesterol-lowering therapy. Int J Clin Pract. 55:2001;710-716.
4. Farnier M. Ezetimibe in hypercholesterolemia. Int J Clin Pract. 56:2002;611-614.
5. Summary of the Third Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA 2001;285:2486-2497